Related references
Note: Only part of the references are listed.Mapping sites of aspirin-induced acetylations in live cells by quantitative acid-cleavable activity-based protein profiling (QA-ABPP)
Jigang Wang et al.
SCIENTIFIC REPORTS (2015)
Aspirin Prevents Colorectal Cancer by Normalizing EGFR Expression
Haitao Li et al.
EBIOMEDICINE (2015)
Phospho-aspirin (MDC-22) inhibits breast cancer in preclinical animal models: an effect mediated by EGFR inhibition, p53 acetylation and oxidative stress
Liqun Huang et al.
BMC CANCER (2014)
Molecular targets of aspirin and cancer prevention
L. Alfonso et al.
BRITISH JOURNAL OF CANCER (2014)
Mutant p53 in Cancer: New Functions and Therapeutic Opportunities
Patricia A. J. Muller et al.
CANCER CELL (2014)
Unravelling mechanisms of p53-mediated tumour suppression
Kathryn T. Bieging et al.
NATURE REVIEWS CANCER (2014)
An Alkyne-Aspirin Chemical Reporter for the Detection of Aspirin-Dependent Protein Modification in Living Cells
Leslie A. Bateman et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
Aspirin Inhibits mTOR Signaling, Activates AMP-Activated Protein Kinase, and Induces Autophagy in Colorectal Cancer Cells
Farhat V. N. Din et al.
GASTROENTEROLOGY (2012)
Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials
Peter M. Rothwell et al.
LANCET (2012)
The role of aspirin in cancer prevention
Michael J. Thun et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2012)
Aspirin Inhibits Colon Cancer Cell and Tumor Growth and Downregulates Specificity Protein (Sp) Transcription Factors
Satya Pathi et al.
PLOS ONE (2012)
Translating p53 into the clinic
Chit Fang Cheok et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
The multiple levels of regulation by p53 ubiquitination
J. T. Lee et al.
CELL DEATH AND DIFFERENTIATION (2010)
Restoration of DNA-Binding and Growth-Suppressive Activity of Mutant Forms of p53 Via a PCAF-Mediated Acetylation Pathway
Ricardo E. Perez et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2010)
Pharmacological reactivation of mutant p53: from protein structure to the cancer patient
K. G. Wiman
ONCOGENE (2010)
p53 post-translational modification: deregulated in tumorigenesis
Chao Dai et al.
TRENDS IN MOLECULAR MEDICINE (2010)
Modifications of p53: competing for the lysines
Stephanie Carter et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2009)
SAM-T08, HMM-based protein structure prediction
Kevin Karplus
NUCLEIC ACIDS RESEARCH (2009)
Restoration of p53 to limit tumor growth
Wenge Wang et al.
CURRENT OPINION IN ONCOLOGY (2008)
Acetylation of the p53 DNA-binding domain regulates apoptosis induction
Stephen M. Sykes et al.
MOLECULAR CELL (2006)
Effect of aspirin on the Wnt/β-catenin pathway is mediated via protein phosphatase 2A
C. L. Bos et al.
ONCOGENE (2006)
Therapeutic levels of aspirin and salicylate directly inhibit a model of angiogenesis through a Cox-independent mechanism
Gillian M. Borthwick et al.
FASEB JOURNAL (2006)
Aspirin induces apoptosis through the inhibition of proteasome function
Priyanka Dikshit et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Distinct p53 acetylation cassettes differentially influence gene-expression patterns and cell fate
Chad D. Knights et al.
JOURNAL OF CELL BIOLOGY (2006)
Reactivation of mutant p53 and induction of apoptosis in human tumor cells by maleimide analogs
VJN Bykov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
The p53 pathway: positive and negative feedback loops
SL Harris et al.
ONCOGENE (2005)
Activation of the caspase-8/Bid and Bax pathways in aspirin-induced apoptosis in gastric cancer
Q Gu et al.
CARCINOGENESIS (2005)
To die or not to die: how does p53 decide?
EA Slee et al.
ONCOGENE (2004)
Non-steroidal anti-inflammatory drugs inhibit cellular proliferation and upregulate cyclooxygenase-2 protein expression in endometrial cancer cells
JC Gao et al.
CANCER SCIENCE (2004)
Post-translational modification of p53 in tumorigenesis
AM Bode et al.
NATURE REVIEWS CANCER (2004)
Activation of p53 signalling in acetylsalicylic acid-induced apoptosis in OC2 human oral cancer cells
CC Ho et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2003)
Daily soluble aspirin and prevention of colorectal adenoma recurrence: One-year results of the APACC trial
R Benamouzig et al.
GASTROENTEROLOGY (2003)
A randomized trial of aspirin to prevent colorectal adenomas
JA Baron et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer
RS Sandler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Non-steroidal anti-inflammatory drugs induce apoptosis in gastric cancer cells through up-regulation of bax and bak
XM Zhou et al.
CARCINOGENESIS (2001)
p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements
P Campomenosi et al.
ONCOGENE (2001)
Aspirin induces apoptosis through release of cytochrome c from mitochondria
KC Zimmermann et al.
NEOPLASIA (2000)
Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation
MS Rodriguez et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Aspirin induces apoptosis through mitochondrial cytochrome c release
M Pique et al.
FEBS LETTERS (2000)
Share Paper
